Corrigendum: (-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B.

Front Pharmacol

School of Medicine, Jiangnan University, Wuxi, China.

Published: May 2018

[This corrects the article on p. 195 in vol. 9, PMID: 29593532.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938370	PMC
http://dx.doi.org/10.3389/fphar.2018.00459	DOI Listing

Publication Analysis

corrigendum --epigallocatechin-3-gallate

--epigallocatechin-3-gallate ameliorates

ameliorates atherosclerosis

atherosclerosis modulates

modulates hepatic

hepatic lipid

lipid metabolic

metabolic gene

gene expression

expression apolipoprotein

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!